Dr. László Tabár and Tony Hsiu-Hsi Chen, DDS, PhD[email protected]BreastWe do not want to go back to the Dark Ages of breast screeningThe publication of long-term follow-up results in BMJ from the Canadian National Breast Screening Study has revived an ongoing debate over the methods used in the trial. In this Second Opinion article, Dr. László Tabár of the University of Uppsala presents his view of the study.February 11, 2014Page 1 of 1Top StoriesAIU.S. FDA may need to clarify SaMD validation standardsIn a video interview, a Dana-Farber Cancer Institute expert describes what the "rigor spectrum" is in validation study designs.Molecular ImagingPSMA-PET/CT may replace NaF-PET/CT in advanced prostate cancerWomens ImagingPreop breast MRI improves surgical planning, but use disparities remainWomens ImagingFIGO classification from MRI leads to moderate agreement among radsSponsor ContentRegister Now: Breaking Barriers in Breast Imaging Webinar